Upexi Inc. (UPXI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Upexi Inc. (UPXI) has a cash flow conversion efficiency ratio of 0.092x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.78 Million) by net assets ($-51.92 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Upexi Inc. (UPXI) defensive interval to measure how many days the company can operate on defensive assets alone.
Upexi Inc. - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Upexi Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Upexi Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Upexi Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Glomac Bhd
KLSE:5020
|
-0.010x |
|
MINDs Lab Inc.
KQ:377480
|
-0.082x |
|
Herige SA
PA:ALHRG
|
0.119x |
|
Oriental Food Industries Hold
KLSE:7107
|
0.047x |
|
Harmoney Corp Ltd
AU:HMY
|
0.514x |
|
Spirax Group plc
LSE:SPX
|
0.147x |
|
Millie Seojae.
KQ:418470
|
0.040x |
|
Onward Technologies Limited
NSE:ONWARDTEC
|
0.138x |
Annual Cash Flow Conversion Efficiency for Upexi Inc. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Upexi Inc. from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see UPXI company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $90.10 Million | $-8.42 Million | -0.093x | -500.88% |
| 2024-06-30 | $6.52 Million | $-101.38K | -0.016x | -313.69% |
| 2023-06-30 | $27.84 Million | $202.68K | 0.007x | -59.84% |
| 2022-06-30 | $28.79 Million | $521.87K | 0.018x | -86.91% |
| 2021-06-30 | $21.22 Million | $2.94 Million | 0.139x | +107.25% |
| 2020-06-30 | $2.18 Million | $-4.16 Million | -1.911x | -923.37% |
| 2019-06-30 | $6.40 Million | $-1.19 Million | -0.187x | -- |
About Upexi Inc.
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its pr… Read more